Mesa Laboratories
MLAB
159 hedge funds and large institutions have $833M invested in Mesa Laboratories in 2022 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 63 increasing their positions, 49 reducing their positions, and 23 closing their positions.
29% more repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 49
22% more capital invested
Capital invested by funds: $681M → $833M (+$153M)
2.75% more ownership
Funds ownership: 91% → 93.75% (+2.7%)
9% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 23
2% less funds holding
Funds holding: 163 → 159 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$36.8M |
| 2 |
GCM
Geneva Capital Management
Milwaukee,
Wisconsin
|
+$13.6M |
| 3 |
CCA
Conestoga Capital Advisors
Wayne,
Pennsylvania
|
+$13.6M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$6.56M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$4.43M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Royce & Associates
New York
|
-$14.2M |
| 2 |
Schroder Investment Management Group
London,
United Kingdom
|
-$6.38M |
| 3 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$3.29M |
| 4 |
Russell Investments Group
London,
United Kingdom
|
-$2M |
| 5 |
State of New Jersey Common Pension Fund D
Trenton,
New Jersey
|
-$1.96M |
MLAB Hedge Fund Activity: Q4 2022 in Review
159 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Mesa Laboratories (MLAB) for Q4 2022, worth a combined $833M — up 22% from $681M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new MLAB positions and 23 closed out — a net gain of 2 holders — while 63 added to existing stakes and 49 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $36.8M. The largest seller was Royce & Associates, cutting an estimated $14.2M.
- 159 institutional investors held Mesa Laboratories (MLAB) as of Q4 2022, down from 163 in Q3 2022.
- Funds reported $833M of Mesa Laboratories stock for Q4 2022, up 22% quarter-over-quarter.
- 25 funds opened new Mesa Laboratories positions in Q4 2022 and 23 closed out, a net change of +2 holders.
- The largest Mesa Laboratories buyer in Q4 2022 was Morgan Stanley, an estimated $36.8M added.
- The largest Mesa Laboratories seller in Q4 2022 was Royce & Associates, an estimated $14.2M sold.
Based on aggregated 13F filings for Q4 2022.